Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
100% Natural Serving Value
The GLP-1 receptor agonists studied included semaglutide (Wegovy/Ozempic, Novo Nordisk), exenatide (Bydureon, AstraZeneca), liraglutide (Saxenda, Novo Nordisk) and dulaglutide (Trulicity, Eli Lilly)
The compound exists in a legal gray zone as a research chemical legal to possess, unlawful to sell as a therapeutic product
Clinical Evidence: Head-to-Head PT-141 Clinical Data PT-141 has the stronger regulatory evidence: FDA-approved as bremelanotide for HSDD in premenopausal women (2019) Phase III trials (RECONNECT) demonstrated statistically significant improvement in sexual desire and reduction in distress Efficacy shown in both male and female sexual dysfunction studies Well-established safety profile across large clinical trials Dose-limiting side effect: nausea (40%+ incidence at approved dose) Kisspeptin Clinical Data Kisspeptin has compelling but earlier-stage evidence: IVF oocyte maturation: Successfully used as an alternative to hCG in multiple clinical trials, with zero OHSS cases (Jayasena et al., 2014
do not consume after the expiry date
A quick search of the hashtag #Peptide yields over 342,000 videos on TikTok, many of them showing users step-by-step tutorials, detailing everything from peptide stacks to dosing schedules and how toinject them at home
US$ 27.22
US$ 24.81
US$ 25.94
